[This corrects the article DOI: 10.1186/s40560-017-0223-2.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941260 | PMC |
| http://dx.doi.org/10.1186/s40560-019-0423-z | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Abdominal myosteatosis measured with computed tomography predicts poor outcomes in patients with glioblastoma.
Neurooncol Adv
November 2024
Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, Saint Louis, Missouri, USA.
Background: Alterations in cellular metabolism affect cancer survival and can manifest in metrics of body composition. We investigated the effects of various body composition metrics on survival in patients with glioblastoma (GBM).
Methods: We retrospectively analyzed patients who had an abdominal and pelvic computed tomography (CT) scan performed within 1 month of diagnosis of GBM (178 participants, 102 males, 76 females, median age: 62.
Correction: Breastfeeding support as predictors of sustainable breastfeeding practices of nursing mothers with common mental disorders in tertiary hospital nurseries in Nigeria: a cross sectional study.
BMC Pregnancy Childbirth
January 2025
Department of Pediatrics, College of Medicine, University of Ibadan & University College Hospital, Ibadan, Ibadan, Oyo State, Nigeria.
Perivascular Space Analysis: A Possible Tool for Predicting Cerebral Amyloid Angiopathy in Pathology‐Confirmed Cases.
Alzheimers Dement
December 2024
USC Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
Background: Diagnosis of cerebral amyloid angiopathy (CAA) presents a significant challenge in determining whether to propose anti‐amyloid treatment plans. The identification of perivascular spaces (PVS) through MRI serves as a possible strategy to elucidate the physiopathological interconnections between the brain's clearance mechanisms and the accumulation of amyloid. This study endeavors to the association between PVS morphology and CAA pathology.
View Article and Find Full Text PDFATN plasma biomarkers and digital cognitive performance in adults with type 1 diabetes: data from the GluCog study.
Alzheimers Dement
December 2024
Elson S. Floyd College of Medicine, Washington State University, Spokane, WA, USA
Background: Highly specific ATN plasma biomarker assays for neurodegenerative diseases have been developed, but their associations with cognition vary in different populations. Kidney disease, common in diabetes, may decrease the predictive precision of those biomarkers. The aim of this study was to characterize for the first time the relationships between plasma ATN biomarkers and cognitive function in adults with T1D.
View Article and Find Full Text PDFCombination of CSF synaptic biomarkers and qEEG leads to a better prediction of disease progression in Alzheimer’s disease.
Alzheimers Dement
December 2024
Amsterdam Neuroscience, Neurodegeneration, Amsterdam, Netherlands
Background: Synaptic dysfunction plays an important role in Alzheimer’s disease (AD) and cognitive decline. We investigated the association between cerebrospinal fluid (CSF) synaptic protein levels and quantitative EEG (qEEG) measures, two modalities to measure synaptic dysfunction in AD pathology. We assessed combined and independent prognostic value of both modalities for cognitive decline along the AD continuum.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!